Life Sciences IP Summit 2022

Finnegan is a sponsor of the C5 Life Sciences IP Summit. Finnegan attorney Antje Brambrink will join the panel discussion “Devising Successful Strategies for Procuring and Maintaining Patents in the New Unitary Patent Era,” Bryan Diner will co-present "Maximizing the Chances of Success in a Bet-the-Company Pharmaceutical Litigation," and Caroline Haas will join the panel discussion “Maximizing the Success of Litigation.” Additionally, Ningling Wang will join the panel discussion “Interactive Roundtable on Transnational Tactics for Claiming and Enforcing Formulation, Combination and Second Medical Use Patents.” The conference will take place at the Westin Grand Munich in Munich, Germany. For more information, or to register, please see C5’s website.